Karen Jean Ferrante Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen Jean Ferrante.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen Jean Ferrante. Karen Jean Ferrante is in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in MACROGENICS INC ($MGNX) and Head Res. & Dev. & Chief Med. in Tokai Pharmaceuticals Inc ($TKAI) and Director in Unum Therapeutics Inc. ($UMRX) and Director in Baxalta Inc ($BXLT).
Latest Insider Trading Transactions of Karen Jean Ferrante
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BXLT, COGT, ELDN, MGNX, PGNX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | COGT | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 9.08 | 2,121 | 19,259 | 2,121 | |
| Mar 15 2021 | UMRX | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 8.45 | 60,000 | 507,000 | 60,000 | |
| Jan 06 2021 | UMRX | Cogent Biosciences ... | Ferrante Karen Jean | Director | Option Exercise | A | 7.62 | 1,575 | 12,000 | 1,575 | |
| Oct 02 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 2.26 | 8,878 | 20,064 | 8,878 | |
| Jul 06 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 0.47 | 38,487 | 18,089 | 38,487 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 5.74 | 25,000 | 143,500 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 8.99 | 25,000 | 224,750 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.89 | 20,000 | 97,800 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.95 | 20,000 | 139,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.72 | 20,000 | 134,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.89 | 20,000 | 97,800 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.47 | 20,000 | 89,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 6.72 | 20,000 | 134,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.50 | 40,000 | 180,000 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.47 | 20,000 | 89,400 | 0 | |
| Jun 23 2020 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | D | 4.50 | 40,000 | 180,000 | 0 | |
| Jun 11 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 0.63 | 14,331 | 9,029 | 14,331 | |
| May 15 2020 | MGNX | MACROGENICS INC | Ferrante Karen Jean | Director | Option Exercise | A | 24.97 | 15,000 | 374,550 | 15,000 | |
| Apr 08 2020 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 0.35 | 54,422 | 19,020 | 54,422 | |
| Oct 03 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 1.41 | 13,646 | 19,241 | 13,646 | |
| Jul 15 2019 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 5.74 | 25,000 | 143,500 | 25,000 | ||
| Jul 03 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 2.41 | 6,199 | 14,940 | 6,199 | |
| Jun 20 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 2.70 | 14,331 | 38,694 | 14,331 | |
| May 20 2019 | MGNX | MACROGENICS INC | Ferrante Karen Jean | Director | Option Exercise | A | 18.00 | 4,616 | 83,088 | 4,616 | |
| May 20 2019 | MGNX | MACROGENICS INC | Ferrante Karen Jean | Director | Option Exercise | A | 18.00 | 10,000 | 180,000 | 10,000 | |
| Apr 03 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.40 | 4,047 | 17,807 | 4,047 | |
| Jan 04 2019 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.47 | 4,073 | 18,206 | 4,073 | |
| Oct 03 2018 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 10.37 | 1,769 | 18,345 | 1,769 | |
| Sep 26 2018 | UMRX | Unum Therapeutics ... | Ferrante Karen Jean | Director | Option Exercise | A | 14.57 | 1,261 | 18,373 | 1,261 | |
| Jun 14 2018 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 8.99 | 25,000 | 224,750 | 25,000 | ||
| May 21 2018 | MGNX | MACROGENICS INC | Ferrante Karen Jean | Director | Option Exercise | A | 21.34 | 10,000 | 213,400 | 10,000 | |
| Jun 15 2017 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 6.95 | 20,000 | 139,000 | 20,000 | ||
| May 22 2017 | MGNX | MACROGENICS INC | Ferrante Karen Jean | Director | Option Exercise | A | 19.57 | 10,000 | 195,700 | 10,000 | |
| Jan 25 2017 | MGNX | MACROGENICS INC | Ferrante Karen Jean | Director | Option Exercise | A | 18.52 | 20,000 | 370,400 | 20,000 | |
| Jun 09 2016 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Option Exercise | A | 4.89 | 20,000 | 97,800 | 20,000 | ||
| Jun 07 2016 | BXLT | Baxalta Inc | Ferrante Karen Jean | Director | Option Exercise | D | 30.60 | 5,960 | 182,376 | 0 | |
| Jun 07 2016 | BXLT | Baxalta Inc | Ferrante Karen Jean | Director | Sell | D | 0.00 | 7,657 | 0 | 0 | 7.7 K to 0 (-100.00 %) |
| May 12 2016 | BXLT | Baxalta Inc | Ferrante Karen Jean | Director | Grant | A | 0.00 | 4,500 | 0 | 7,657 | 3.2 K to 7.7 K (+142.54 %) |
| Dec 17 2015 | TKAI | Tokai Pharmaceutic ... | Ferrante Karen Jean | Head Res. & Dev. & ... | Option Exercise | A | 9.65 | 62,000 | 598,300 | 62,000 | |
| Jul 29 2015 | BXLT | Baxalta Inc | Ferrante Karen Jean | Director | Option Exercise | A | 30.60 | 5,960 | 182,376 | 5,960 | |
| Jul 29 2015 | BXLT | Baxalta Inc | Ferrante Karen Jean | Director | Grant | A | 0.00 | 3,140 | 0 | 3,140 | 6.3 K to 3.1 K (-50.00 %) |
| Jun 11 2015 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | A | 6.72 | 20,000 | 134,400 | 20,000 | |
| Jun 19 2014 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.47 | 20,000 | 89,400 | 20,000 | |
| Jan 30 2014 | PGNX | PROGENICS PHARMACE ... | Ferrante Karen Jean | Director | Option Exercise | A | 4.50 | 40,000 | 180,000 | 40,000 |
Page: 1